Extracellular matrix modulation of vascular cell behaviour

Transplant Immunology

Volumn 5, Issue 3, 1997, Pages 179-183

  Madri, Joseph A ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR;

BLOOD VESSEL; CELL INTERACTION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030702836     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80035-4     Document Type: Conference Paper

References (36)

1. Madri JA, Pratt BM, Yannariello-Brown J. Matrix driven cell size changes modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol. 132:1988;18-27.
2. Madri JA, Bell L. Vascular cell responses to injury: modulation by extracellular matrix and soluble factors. Robenek H, Severs N. Atherosclerosis. 1992;165-179 CRC Press, Boca Raton, FL.
3. Madri JA, Marx M. Matrix composition, organization and soluble factors: Modulators of microvascular cell differentiation in vitro. Kidney Int. 41:1992;560-565.
4. Madri JA, Merwin JR, Bell L, Simionescu M, et al. Interactions of matrix components and soluble factors in vascular responses to injury: modulation of cell phenotype. Simionescu N. Endothelial cell dysfunction. 1992;11-30 Plenum Press, New York.
5. Madri JA, Sankar S, Romanic AM. Angiogenesis. Clark RAF. The molecular and cellular biology of wound healing. 1995;355-371 Plenum Press, New York.
6. Merwin JR, Anderson J, Kocher O, et al. Transforming growth factor β1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol. 142:1990;117-128.
7. Gamble JR, Matthias LJ, Meyer G, et al. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol. 121:1993;931-943.
8. George EL, Georges EN, Patel-King RS, et al. Defects in mesodermal migration and vascular development in fibronectin-deficient mice. Development. 119:1993;1079-1091.
9. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 8:1994;929-937.
10. Friedlander M, Brooks PC, Shaffer RW, et al. Definition of two angiogenic pathways by distinct av integrins. Science. 270:1995;1500-1502.
11. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in α5 integrin-deficient mice. Development. 119:1993;1093-1105.
12. Battegay EJ, Rupp J, Iruela-Arispe L, et al. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGFb-receptors. J Cell Biol. 125:1994;917-928.
13. Sankar S, Mahooti-Brooks N, Bensen L, et al. Modulation of transforming growth factor beta receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest. 97:1996;1436-1446.
14. Marx M, Daniel TO, Kashgarian M, et al. Spatial organization of the extracellular matrix modulates the expression of PDGF-receptor subunits in mesangial cells. Kidney Int. 43:1993;1027-1041.
15. Marx M, Perlmutter R, Madri JA. Modulation of PDGF-receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest. 93:1994;131-139.
16. Sankar S, Mahooti-Brooks N, Centrella M, et al. Expression of transforming growth factor beta type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor β2. J Biol Chem. 270:1995;13567-13572.
17. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J Cell Biol. 106:1988;1375-1384.
18. Madri JA, Sankar S. The biphasic effects of TGFβ in angiogenesis. Lewis CE, Bicknell R, Ferrera N. Tumour angiogenesis. 1997;Oxford University Press, Oxford.
19. Madri JA, Reidy M, Kocher O, et al. Endothelial cell behaviour after denudation injury is modulated by TGF-β and fibronectin. Lab Invest. 60:1989;755-765.
20. Madri JA, Kocher O, Merwin JR, et al. The interactions of vascular cells with transforming growth factor β Piez KA, Sporn MB. Transforming growth factor-βs: chemistry, biology and theraputics. 593:1990;243-258.
21. Petzelbauer E, Springhorn JP, Tucker A, et al. The role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-β1. Am J Pathol. 149:1996;923-931.
22. Ingber DE. Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc Natl Acad Sci USA. 87:1990;3579-3583.
23. Schwartz MA, Lechene C, Ingber DE. Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin α5β1, independent of cell shape. Proc Natl Acad Sci USA. 88:1991;7849-7853.
24. Guan JL, Trevethick JE, Hynes RO. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120kD protein. Cell Reg. 2:1991;951-964.
25. FAK phosphorylation. Am J Pathol. 147:1995;601-608.
26. Lu TT, Yan LG, Madri JA. Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule-1 (PECAM-1). Proc Natl Acad Sci USA. 93:1996;11808-11813.
27. Albelda SM, Oliver PD, Romer LH, et al. EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol. 110:1990;1227-1237.
28. Schimmenti L, Yan H-C, Madri JA, et al. Platelet endothelial cell adhesion molecule PECAM-1 modulates cell migration. J Cell Physiol. 153:1992;417-428.
29. Madri JA, Bell L, Merwin JR. Modulation of vascular cell behaviour by transforming growth factors beta. Mol Rep Devel. 32:1992;21-126.
30. DeLisser HM, Christofidou-Solomidou M, Strieter RM, et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol. 1997;. in press.
31. Songyang Z, Shoelson SE, Chaudhuri M, et al. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
32. Pinter E, Barreuther M, Lu TT, et al. PECAM-1/CD31 tyrosine phosphorylation state changes during vasculogenesis. Am J Pathol. 150:1997;1523-1530.
33. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in α5 integrin-deficient mice. Development. 119:1993;1093-1105.
34. Dickson MC, Martin JS, Cousins FM, et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 121:1995;1845-1854.
35. Form DM, Pratt BM, Madri JA. Endothelial cell proliferation during angiogenesis: in vitro modulation by basement membrane components. Lab Invest. 55:1986;521-530.
36. Nicosia RF, Madri JA. The microvascular extracellular matrix: Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol. 128:1987;78-90.